PHASE-I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (VOL 85, PG 1499, 1993)

Authors
SALTZ L SIROTT M YOUNG C
Citation
L. Saltz et al., PHASE-I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (VOL 85, PG 1499, 1993), Journal of the National Cancer Institute, 85(21), 1993, pp. 1777-1777
Citations number
1
Categorie Soggetti
Oncology
Journal title
Journal of the National Cancer Institute → ACNP
Volume
85
Issue
21
Year of publication
1993
Pages
1777 - 1777
Database
ISI
SICI code